ConversionPoint Holdings Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
/
Date18 Dec 2018
Email Print Friendly Share NEWPORT BEACH, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) — ConversionPoint Holdings, Inc. today announced that in connection with the proposed acquisition... Read More →
Synthorx Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
/
Date16 Dec 2018
Email Print Friendly Share SAN DIEGO, Dec. 12, 2018 (GLOBE NEWSWIRE) — Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet... Read More →
360 Finance Announces Pricing of Initial Public Offering
/
Date15 Dec 2018
Email Print Friendly Share SHANGHAI, China, Dec. 14, 2018 (GLOBE NEWSWIRE) — 360 Finance, Inc. (NASDAQ: QFIN) (“360 Finance” or the “Company”), a leading digital consumer... Read More →
Legacy Housing Corp. Announces Pricing of Initial Public Offering
/
Date14 Dec 2018
Email Print Friendly Share 24-Wide Home Model Model: S-2448-22FLP-1 Legacy Housing Corporation Tiny Hacienda Model: 1234-11FLA-1 Legacy Housing Corporation DALLAS, Dec. 14, 2018 (GLOBE NEWSWIRE)... Read More →
VBI Vaccines Announces Pricing of $37.5 Million Public Offering
/
Date13 Dec 2018
Email Print Friendly Share CAMBRIDGE, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) — VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious... Read More →
Gegs Capital Corp. Announces Closing of Initial Public Offering
/
Date10 Dec 2018
Email Print Friendly Share NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWS WIRES CALGARY, Alberta, Dec. 10, 2018 (GLOBE NEWSWIRE) — Gegs... Read More →
Synthorx Announces Pricing of Initial Public Offering
/
Date09 Dec 2018
Email Print Friendly Share SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) — Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet... Read More →
DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING
/
Date08 Dec 2018
Email Print Friendly Share MINNEAPOLIS, Dec. 07, 2018 (GLOBE NEWSWIRE) — DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX‑V:DMA), a clinical stage biopharmaceutical company, announced today the... Read More →
Tonix Pharmaceuticals Prices $15,000,000 Public Offering
/
Date07 Dec 2018
Email Print Friendly Share NEW YORK, Dec. 07, 2018 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical... Read More →
Adform postpones its Initial Public Offering
/
Date04 Dec 2018
Email Print Friendly Share Company Announcement No. 5/2018 Copenhagen, 4 December 2018 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY... Read More →